Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (131-140 of 210) with videos related to

Pageof 21
Sort By:
Plos One|January 28, 2014
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenPaul F McKay, Alethea V Cope, Jamie F S Mann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2013
CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissueKai Hu, Sukun Luo, Lina Tong, et al.
Frontiers in Immunology|May 21, 2016
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis ClearanceAlexander Badamchi-Zadeh, Paul F McKay, Bette T Korber, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2023
Omicron breakthrough infections in vaccinated or previously infected hamstersJie Zhou, Ksenia Sukhova, Thomas P Peacock, et al.
Journal of Virology|August 23, 2013
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challengeKatja Klein, Ronald S Veazey, Ranjit Warrier, et al.
FEMS Immunology and Medical Microbiology|March 3, 2007
Chemokine/cytokine production by mononuclear cells from human lymphoid tissues and their modulation by Mycobacterium tuberculosis antigensMauricio A Arias, Adelis E Pantoja, Gabriela Jaramillo, et al.
Journal of Virology|November 1, 2016
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing AntibodiesHannah M Cheeseman, Natalia J Olejniczak, Paul M Rogers, et al.
Vaccine|February 25, 2012
Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage formAditya Pattani, Paul F McKay, Rhonda M Curran, et al.
Retrovirology|June 10, 2015
Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopesPaul J Peters, Maria Paz Gonzalez-Perez, Thomas Musich, et al.
The Journal of Allergy and Clinical Immunology|April 20, 2019
Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humansFränze Progatzky, Akhilesh Jha, Madina Wane, et al.
Pageof 21

Showing results (131-140 of 210) with videos related to

Sort By:
Pageof 21
Plos One|January 28, 2014
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenPaul F McKay, Alethea V Cope, Jamie F S Mann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2013
CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissueKai Hu, Sukun Luo, Lina Tong, et al.
Frontiers in Immunology|May 21, 2016
A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis ClearanceAlexander Badamchi-Zadeh, Paul F McKay, Bette T Korber, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2023
Omicron breakthrough infections in vaccinated or previously infected hamstersJie Zhou, Ksenia Sukhova, Thomas P Peacock, et al.
Journal of Virology|August 23, 2013
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challengeKatja Klein, Ronald S Veazey, Ranjit Warrier, et al.
FEMS Immunology and Medical Microbiology|March 3, 2007
Chemokine/cytokine production by mononuclear cells from human lymphoid tissues and their modulation by Mycobacterium tuberculosis antigensMauricio A Arias, Adelis E Pantoja, Gabriela Jaramillo, et al.
Journal of Virology|November 1, 2016
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing AntibodiesHannah M Cheeseman, Natalia J Olejniczak, Paul M Rogers, et al.
Vaccine|February 25, 2012
Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage formAditya Pattani, Paul F McKay, Rhonda M Curran, et al.
Retrovirology|June 10, 2015
Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopesPaul J Peters, Maria Paz Gonzalez-Perez, Thomas Musich, et al.
The Journal of Allergy and Clinical Immunology|April 20, 2019
Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humansFränze Progatzky, Akhilesh Jha, Madina Wane, et al.
Pageof 21